Page 1 | Search Results | Blood | American Society of Hematology

1-20 of 35

Sort by

Sort Order Select

Journal Articles

Banked, GMP Grade Third Party T-Cell Lines Specific for CMVpp65 Epitopes Presented By Certain Prevalent HLA Alleles More Consistently Clear CMV Infections in a Genetically Heterogeneous Population of HSCT Recipients

Aisha N. Hasan, MD, Susan E. Prockop, MD, Guenther Koehne, MD PhD, Ekaterina Doubrovina, MD PhD, Richard J. O'Reilly, MD

Blood (2014) 124 (21): 309.

https://doi.org/10.1182/blood.V124.21.309.309

Published: 2014

Journal Articles

Myeloablative Double-Unit Cord Blood Transplantation (CBT) in Pediatric Patients with High-Risk Acute Leukemia Demonstrates Encouraging Disease-Free Survival with Both TBI and Chemotherapy-Only-Based Conditioning

Andromachi Scaradavou, MD, Marissa N Lubin, BA, Patrick Hilden, MS, Farid Boulad, MD, Kevin J. Curran, MD, Rachel Kobos, MD, Susan E. Prockop, MD, Richard J. O'Reilly, MD, Jo-Ann Tonon, Courtney Byam, BS, Peter G Steinherz, MD, Neerav Shukla, MD, Aisha Hasan, MD, Thomas M. Renaud, MD, Nicole Zakak, N.P., Nancy A. Kernan, MD, Juliet N. Barker, MBBS(Hons), FRACP

Blood (2014) 124 (21): 2578.

https://doi.org/10.1182/blood.V124.21.2578.2578

Published: 2014

Journal Articles

Third Party Donor Derived CMV Specific T Cells for the Treatment of Refractory CMV Viremia and Disease after Hematopoietic Stem Cell Transplant

Susan E. Prockop, MD, Aisha Hasan, MD, Guenther Koehne, MD PhD, Ekaterina Doubrovina, MD PhD, Craig S. Sauter, MD, Juliet N, Barker, MBBS, Karim Baroudy, Farid Boulad, MD, Sergio Giralt, MD, Ramzi Khalaf, Nancy A. Kernan, MD, Esperanza B Papadopoulos, MD, Doris M. Ponce, MD, Andromachi Scaradavou, MD, Stephanie Suser, Gloria Wasilewski, RN, Richard J. O'Reilly, MD

Blood (2014) 124 (21): 184.

https://doi.org/10.1182/blood.V124.21.184.184

Published: 2014

Journal Articles

Chimeric Antigen Receptor (CAR) T Cells Targeting the CD19 Antigen for the Treatment of Pediatric Relapsed B Cell ALL

Kevin J. Curran, MD, Isabelle Riviere, PhD, Rachel Kobos, MD, Nancy A. Kernan, MD, Farid Boulad, MD, Susan E. Prockop, MD, Andromachi Scaradavou, MD, Thomas M. Renaud, MD, Neerav Shukla, MD, Peter G Steinherz, MD, Jae H Park, MD, Craig S. Sauter, MD, Richard J O'Reilly, MD, Michel Sadelain, MD PhD, Renier J. Brentjens, MD PhD

Blood (2014) 124 (21): 3716.

https://doi.org/10.1182/blood.V124.21.3716.3716

Published: 2014

Journal Articles

Second Allogeneic Stem Cell Transplantation for Hematologic Malignancies Using Chemotherapy Only Cytoreduction with Clofarabine, Melphalan, and Thiotepa

Barbara Spitzer, MD, Miguel-Angel Perales, MD, Nancy A. Kernan, MD, Susan E. Prockop, MD, Nicholas Webb, Hugo Castro-Malaspina, MD, Esperanza B Papadopoulos, MD, James W. Young, MD, Andromachi Scaradavou, MD, Rachel Kobos, MD, Sergio Giralt, MD, Richard J O'Reilly, MD, Farid Boulad, MD

Blood (2014) 124 (21): 3942.

https://doi.org/10.1182/blood.V124.21.3942.3942

Published: 2014

Journal Articles

Generation and Characterization Of a Third Party GMP Grade Bank Of CMV Specific T-Cells For Adoptive Immunotherapy Of CMV Infections In Recipients Of HSCT From Cord Blood Or Seronegative Donors

Aisha N. Hasan, MD, Ekaterina Doubrovina, MD, PhD, Guenther Koehne, MD, PhD, Susan E. Prockop, MD, Richard J. O'Reilly, MD

Blood (2013) 122 (21): 2021.

https://doi.org/10.1182/blood.V122.21.2021.2021

Published: 2013

Journal Articles

Intensified Mycophenolate Mofetil (MMF) Dosing Every 8 Hours Is Safe From The Standpoint Of Engraftment and May Ameliorate Severe Acute Graft-Versus-Host Disease (GVHD) After Double-Unit Cord Blood Transplantation (CBT)

Doris M Ponce, MD, Stephen J. Harnicar, PharmD, BCOP, BCPS, Sean Devlin, PhD, Patrick Hilden, MS, Katherine L Evans, BA, Marissa N Lubin, BA, Sergio A Giralt, MD, Jenna D Goldberg, MD, Miguel-Angel Perales, MD, Nancy A. Kernan, MD, Susan E. Prockop, MD, Andromachi Scaradavou, MD, Juliet N Barker, MBBS, (Hons), FRACP

Blood (2013) 122 (21): 4600.

https://doi.org/10.1182/blood.V122.21.4600.4600

Published: 2013

Journal Articles

Late Effects Following Allogeneic Hematopoietic Stem Cell Transplantation (HSCT) From Alternative Donors In Patients With Fanconi Anemia (FA)

Praveen Anur, MD, Danielle Friedman, MD, Charles A. Sklar, MD, Kevin C. Oeffinger, MD, Susan E. Prockop, MD, Nancy A. Kernan, MD, Andromachi Scaradavou, MD, Richard J. O'Reilly, MD, Farid Boulad, MD

Blood (2013) 122 (21): 1233.

https://doi.org/10.1182/blood.V122.21.1233.1233

Published: 2013

Journal Articles

Adoptive Transfer Of WT-1 Specific HLA Class 2 Restricted Donor-Derived T-cells Induces Sustained Remission Of AML Relapse Post Transplant Presenting As Leukemia Cutis

Susan E. Prockop, MD, Ekaterina Doubrovina, MD, PhD, Roberta Adams, MD, Farid Boulad, MD, Nancy A. Kernan, MD, Richard J. O'Reilly, MD

Blood (2013) 122 (21): 2085.

https://doi.org/10.1182/blood.V122.21.2085.2085

Published: 2013

Journal Articles

Allogeneic Hematopoietic Stem Cell Transplantation Of Patients With Wiskott-Aldrich Syndrome With Total Body Irradiation (TBI), Thiotepa and Fludarabine Or Cyclophosphamide Followed By T-Cell Depleted Grafts From Alternative Donors

Susan E. Prockop, MD, Farid Boulad, MD, Nancy A. Kernan, MD, Ramzi Khalif, BA, Rachel Kobos, MD, Andromachi Scaradavou, MD, Richard J. O'Reilly, MD

Blood (2013) 122 (21): 4567.

https://doi.org/10.1182/blood.V122.21.4567.4567

Published: 2013

Journal Articles

Adoptive Treatment Of EBV-Associated Leiomyosarcoma In Immunodeficient Patients With EBV Specific Cytotoxic T Cells

Susan E. Prockop, MD, Ekaterina Doubrovina, MD, PhD, Farid Boulad, MD, Nancy A. Kernan, MD, Rachel Kobos, MD, Andromachi Scaradavou, MD, Sara J. Abramson, MD, Michael Laquaglia, MD, Anita Price, MD, Richard J. O’Reilly, MD

Blood (2013) 122 (21): 3267.

https://doi.org/10.1182/blood.V122.21.3267.3267

Published: 2013

Journal Articles

Two Chemotherapy-Based Conditioning Regimens Compared To TBI-Based Conditioning Secure Consistent Engraftment Of T-Cell Depleted Allogeneic HSCT, Similarly Low Incidences Of Gvhd and Favorable Rates Of Disease-Free Survival (DFS)

Blood (2013) 122 (21): 546.

https://doi.org/10.1182/blood.V122.21.546.546

Published: 2013

Journal Articles

First US Phase I Clinical Trial Of Globin Gene Transfer For The Treatment Of Beta-Thalassemia Major

Farid Boulad, MD, Isabelle Riviere, PhD, Xiuyan Wang, PhD, Shirley Bartido, PhD, Susan E. Prockop, MD, Rita Barone, M.D., Paolo Moi, MD, Aurelio Maggio, M.D., Michel Sadelain, MD, PhD

Blood (2013) 122 (21): 716.

https://doi.org/10.1182/blood.V122.21.716.716

Published: 2013

Journal Articles

Adoptive Immunotherapy with Donor T Cells Sensitized with Overlapping Pentadecapeptides of the CMV-pp65 Protein for the Treatment of Persistent CMV Antigenemia Following Allogeneic Hematopoietic Stem Cell Transplants

Blood (2012) 120 (21): 351.

https://doi.org/10.1182/blood.V120.21.351.351

Published: 2012

Journal Articles

A Novel Chemotherapy-Based Allogeneic Hematopoietic Stem Cell Transplant Regimen for Very Young Children with Leukemia.

Susan E. Prockop, MD, Nancy A. Kernan, MD, Elizabeth G Klein, Rachel Kobos, MD, Andromachi Scaradavou, MD, Trudy N. Small, MD, Richard J. O'Reilly, MD, Farid Boulad, MD

Blood (2012) 120 (21): 3149.

https://doi.org/10.1182/blood.V120.21.3149.3149

Published: 2012

Journal Articles

Clofarabine, Melphalan, and Thiotepa, Followed by Allogeneic Unmodified Bone Marrow or Peripheral Blood Stem Cell Transplant, by Unmodified Double Cord Blood Transplant, or by CD34+ T-Cell Depleted Stem Cell Transplant for the Treatment of Hematologic Malignancies.

Farid Boulad, MD, Guenther Koehne, MD, PhD, Nancy A. Kernan, MD, Susan E. Prockop, MD, Trudy N. Small, MD, Andromachi Scaradavou, MD, Miguel-Angel Perales, MD, Hugo R Castro-Malaspina, MD, Esperanza B. Papadopoulos, MD, Jenna D Goldberg, MD, Elizabeth G Klein, Rachel Kobos, MD, Ann A. Jakubowski, MD, PhD, Doris Ponce, MD, Juliet Barker, MBBS, James W. Young, MD, Craig S. Sauter, MD, Sergio Giralt, MD, Richard J. O'Reilly, MD

Blood (2012) 120 (21): 3144.

https://doi.org/10.1182/blood.V120.21.3144.3144

Published: 2012

Journal Articles

Graft-Versus-Host Disease After Double-Unit Cord Blood Transplantation Has Unique Features and an Association with Engrafting Unit Recipient HLA-Match

Blood (2012) 120 (21): 4197.

https://doi.org/10.1182/blood.V120.21.4197.4197

Published: 2012

Journal Articles

Third Party Donor Derived EBV Specific T Cells for the Treatment of Refractory EBV-Related Malignancies in Immunodeficient Recipients

Susan E. Prockop, MD, Ekaterina Doubrovina, MD, PhD, Juliet N Barker, MBBS, Karim Baroudy, Farid Boulad, MD, Ramzi Khalaf, Nancy A. Kernan, MD, Rachel Kobos, MD, Esperanza B. Papadopoulos, MD, Andromachi Scaradavou, MD, Trudy N Small, MD, Gloria Wasilewski, RN, Richard J. O'Reilly, MD

Blood (2012) 120 (21): 577.

https://doi.org/10.1182/blood.V120.21.577.577

Published: 2012

Journal Articles

Double-Unit Cord Blood Transplantation (DCBT) for Acute Leukemia: High Disease-Free Survival in Adults and Children with Comparable Survival in European and Minority Patients

Blood (2011) 118 (21): 3080.

https://doi.org/10.1182/blood.V118.21.3080.3080

Published: 2011

Journal Articles

Safety and Immunogenicity of the 13-Valent Protein-Conjugated Pneumococcal Vaccine(PCV13) Following Related and Unrelated Hematopoietic Stem Cell Transplantation (HCT)

Trudy N Small, MD, Ann A. Jakubowski, MD, PhD, Juliet N Barker, MBBS, (Hons), FRACP, Nancy A. Kernan, MD, Susan E Prockop, MD, Christine Scura Iovino, APRN-BC, FNP-C, LeStrange Nicole, NP, Miguel-Angel Perales, MD, Hugo Castro-Malaspina, MD, Guenther Koehne, MD, PhD, Sergio Giralt, MD, Esperanza B Papadopoulos, MD

Blood (2011) 118 (21): 3037.

https://doi.org/10.1182/blood.V118.21.3037.3037

Published: 2011

NARROW

Banked, GMP Grade Third Party T-Cell Lines Specific for CMVpp65 Epitopes Presented By Certain Prevalent HLA Alleles More Consistently Clear CMV Infections in a Genetically Heterogeneous Population of HSCT Recipients

Myeloablative Double-Unit Cord Blood Transplantation (CBT) in Pediatric Patients with High-Risk Acute Leukemia Demonstrates Encouraging Disease-Free Survival with Both TBI and Chemotherapy-Only-Based Conditioning

Third Party Donor Derived CMV Specific T Cells for the Treatment of Refractory CMV Viremia and Disease after Hematopoietic Stem Cell Transplant

Chimeric Antigen Receptor (CAR) T Cells Targeting the CD19 Antigen for the Treatment of Pediatric Relapsed B Cell ALL

Second Allogeneic Stem Cell Transplantation for Hematologic Malignancies Using Chemotherapy Only Cytoreduction with Clofarabine, Melphalan, and Thiotepa

Generation and Characterization Of a Third Party GMP Grade Bank Of CMV Specific T-Cells For Adoptive Immunotherapy Of CMV Infections In Recipients Of HSCT From Cord Blood Or Seronegative Donors

Intensified Mycophenolate Mofetil (MMF) Dosing Every 8 Hours Is Safe From The Standpoint Of Engraftment and May Ameliorate Severe Acute Graft-Versus-Host Disease (GVHD) After Double-Unit Cord Blood Transplantation (CBT)

Late Effects Following Allogeneic Hematopoietic Stem Cell Transplantation (HSCT) From Alternative Donors In Patients With Fanconi Anemia (FA)

Adoptive Transfer Of WT-1 Specific HLA Class 2 Restricted Donor-Derived T-cells Induces Sustained Remission Of AML Relapse Post Transplant Presenting As Leukemia Cutis

Allogeneic Hematopoietic Stem Cell Transplantation Of Patients With Wiskott-Aldrich Syndrome With Total Body Irradiation (TBI), Thiotepa and Fludarabine Or Cyclophosphamide Followed By T-Cell Depleted Grafts From Alternative Donors

Adoptive Treatment Of EBV-Associated Leiomyosarcoma In Immunodeficient Patients With EBV Specific Cytotoxic T Cells

Two Chemotherapy-Based Conditioning Regimens Compared To TBI-Based Conditioning Secure Consistent Engraftment Of T-Cell Depleted Allogeneic HSCT, Similarly Low Incidences Of Gvhd and Favorable Rates Of Disease-Free Survival (DFS)

First US Phase I Clinical Trial Of Globin Gene Transfer For The Treatment Of Beta-Thalassemia Major

Adoptive Immunotherapy with Donor T Cells Sensitized with Overlapping Pentadecapeptides of the CMV-pp65 Protein for the Treatment of Persistent CMV Antigenemia Following Allogeneic Hematopoietic Stem Cell Transplants

A Novel Chemotherapy-Based Allogeneic Hematopoietic Stem Cell Transplant Regimen for Very Young Children with Leukemia.

Clofarabine, Melphalan, and Thiotepa, Followed by Allogeneic Unmodified Bone Marrow or Peripheral Blood Stem Cell Transplant, by Unmodified Double Cord Blood Transplant, or by CD34+ T-Cell Depleted Stem Cell Transplant for the Treatment of Hematologic Malignancies.

Graft-Versus-Host Disease After Double-Unit Cord Blood Transplantation Has Unique Features and an Association with Engrafting Unit Recipient HLA-Match

Third Party Donor Derived EBV Specific T Cells for the Treatment of Refractory EBV-Related Malignancies in Immunodeficient Recipients

Double-Unit Cord Blood Transplantation (DCBT) for Acute Leukemia: High Disease-Free Survival in Adults and Children with Comparable Survival in European and Minority Patients

Safety and Immunogenicity of the 13-Valent Protein-Conjugated Pneumococcal Vaccine(PCV13) Following Related and Unrelated Hematopoietic Stem Cell Transplantation (HCT)

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only